Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating

 Dear Sir(s), In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please note that ICRA Limited has upgraded: 1. the long-term rating for Line of Credit of SRL Limited from [ICRA] A- (ICRA A minus) to [ICRA] A (ICRA A); and 2. the long-term rating for Line of Credit of SRL Diagnostics Private Limited from [ICRA] A- (ICRA A minus) to [ICRA] A (ICRA A); and The detailed letters as issued by ICRA Limited are attached for your reference and records.
23-12-2020
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating

 Dear Sir(s), In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please note that CRISIL has assigned credit ratings to the bank facilities of the following wholly owned subsidiaries of the Company: - 1. Escorts Heart Institute and Research Centre Limited; and 2. Fortis Hospotel Limited The detailed letters as issued by CRISIL are attached for your reference and records.
22-12-2020
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Fortis Healthcare Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
14-12-2020
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Proceedings And Voting Result Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Following resolutions were approved with requisite majority through e-voting: - 1. To approve amendment in loan agreement between Fortis Healthcare Limited ('the Company') and Fortis Hospitals Limited ('FHsL'), a wholly owned material subsidiary of the Company and to enable issue of equity shares by FHsL to the Company pursuant to the conversion of said loan 2. To approve amendment in terms of intra group Compulsory Convertible Preference Shares between Fortis Hospitals Limited and Escorts Heart Institute and Research Centre Limited, wholly owned subsidiaries of the Company 3. To consider amendment in loan agreement between Fortis Hospitals Limited ('FHsL') and Fortis C-Doc Healthcare Limited ('Fortis C-Doc'), subsidiaries of the Company and to enable issue of Optionally Convertible Redeemable Preference Shares by Fortis C-Doc to FHsL pursuant to the conversion of loan 4. To approve further investment by SRL Limited into SRL Diagnostics FZ-LLC, a step-down subsidiary of the Company
14-12-2020
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Regulation 23 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015-Disclosure Of Related Party Transactions For The Half Year Ended September 30, 2020.

 In compliance of Regulation 23(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find attached disclosure of Related Party Transactions for the half year ended September 30, 2020. This is for your information and records please.
10-12-2020
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 This is in relation to the captioned subject and pursuant to SEBI Circular ref. no. SEBI/HO/ISD/ISD/CIR/P/2020/135 dated July 23, 2020, wherein process relating to dealing with violations of the Code of Conduct of SEBI PIT was standardized. Please find enclosed an incident of violation marked as Appendix I. At the outset, we would like to assure you of our full co-operation and support in respect of this. As a listed company, we are conscious of our obligations to all our stakeholders and have always strived to ensure the highest levels of compliance within our organization.
08-12-2020
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aberdeen Standard Investments (Asia) Ltd
27-11-2020
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015- SEBI Show Cause Notice

 Dear Sir(s), This is in continuation of our intimation dated October 18, 2018, December 22, 2018, March 20, 2019 and November 13, 2020 with respect to an ad-interim ex-parte order passed by Securities and Exchange Board of India ('SEBI') in the matter relating to the alleged diversion of funds from the Company by its erstwhile promoters. SEBI has issued a show cause notice ('SCN') vide no. SEBI/HO/IVD/ID2/OW/P/2020/19924/1 dated November 20, 2020 in the aforesaid matter to inter alia the Company and Fortis Hospitals Limited (a wholly owned subsidiary of the Company) ('FHsL'). The management and Board of the Company that was newly constituted after NTK Ventures Pte. Ltd. (a wholly owned subsidiary of IHH Healthcare Berhad) became promoters of the Company, are evaluating the SCN in detail, in consultation with its legal advisors. The disclosure as required under Regulation 30 is enclosed as 'Annexure-A'. This is for your information and records please.
21-11-2020
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015- SEBI Order Dated November 12, 2020.

 Dear Sir(s), This is in continuation of our intimation dated October 18, 2018 and December 22, 2018 with respect to an ad-interim ex-parte order passed by Securities and Exchange Board of India (SEBI). In the matter SEBI has issued an order no. WTM/GM/IVD/ID2/48/2020-21 dated November 12, 2020 in the aforesaid matter. A copy of the detailed order is attached for your kind reference. The Company is evaluating the aforesaid order in detail. A detailed disclosure as required under Regulation 30 is enclosed as 'Annexure-A'. This is for your information and records please.
13-11-2020

Fortis Healthcare Q2 net profit declines 88% at Rs 15.47 crore

 Consolidated revenue from the operations stood at Rs 994.70 crore for the quarter under consideration. It was Rs 1,212.17 crore for the same period a year ago, it added.
12-11-2020
Next Page
Close

Let's Open Free Demat Account